With the large numbers of overseas Chinese scientists and entrepreneurs returned to China, and increasing economic growth of China in the past two decades, China like other Asia countries is attracting overseas pharmaceutical and biotech companies in Chinese drug discovery outsourcing market. The driving forces shaping the sector are not only the cost concerns but also the capacity and productivities. The huge pool of talented diligent and responsible Chinese professionals has supported more big and small companies to release their pipeline pressure. Both customers and suppliers are eager to take advantage of such wave. So, you are welcomed to provide Segments, size, and growth of the market analysis to IDDST 2008.

The Sessions of drug discovery outsourcing invite you to tell your story in:

Chemistry Services

Building Blocks

Compound Synthesis

Libraries

Process Research

Other Services

Biology Services

Protein Expression

Structural Analysis

Target Validation

Pathways Analysis

Screening Services

Assay Development

Primary Screening

Secondary Screening

Lead Optimization

Early ADMET

Analogues Creation

Computational Support

Other Services for Drug Discovery

Through the dynamic involvement from you, we hope you can share with our colleagues in:

1) Why Outsourcing?

2) Outsourcing in Drug Discovery

3) Are VCs interested in Promote Outsourcing?

4) Trend of Globalization in Drug Discovery

5) Is Environment & Expectations bothering you?

6) What are the factors shaping the drug discovery outsourcing market?

7) What are the major types of drug discovery services and which are growing fastest?

8) What are the implications of off shoring for this market?

9) What do customers look for in a supplier?

10) What do suppliers do to make themselves successful?

11) Who are the leaders in this market? Who are some promising newcomers?

12) How large is the market and how fast is it growing?

13) The Outsourcing Decision Process

14) Academic vs. Commercial CRO

15) How to Select a CRO

16) Factors Driving the CRO Selection Decision:

17) Negotiating the Deal

18) What factors should a client consider when deciding whether to do a project in-house or outsource it in China or Asia ?

19) Is it in his best interest to seek a domestic outsourcing partner, or go with a Chinese supplier?

20) How does he select the CRO that is best for him?

21) What are the best practices when working with a CRO?

22) How do you measure his effectiveness?

23) How do you avoid problems with your CRO?

24) How do you maximize benefits?

25) Advantages and Disadvantages have become your major concern for domestic suppliers and clients alike.

26) Provide your value opinion on the Pros & Cons on Drug Discovery Outsourcing in India , China , and Eastern Europe by conparing with some of their limitations.

27) Tell Big pharma strategies for offshoring

28) Working with Your CRO

29) Elements of the Contract

30) How to Help Your CRO and Head Off Problems

31) Effective Alliance Management

32) Measuring Effectiveness of a Deal

33) Product Supply Contract

34) Fee-for-Service and Full-Time Equivalent (FTE)

35) Collaborative Research Agreement

36) Non-Exclusive Alliance

37) Exclusive Strategic Alliance

38) How to Doing Outsourcing Business in China ?

39) What Are the Barriers to Integration?

40) What Are the Issues Regarding Language?

41) What Are the Relative Strengths of China in Outsourcing Comparing with other countries?

42) China 's IP and Regulatory Environment

43) Clinical Trials in China

44) China 's Advantages & Limitations

45) The Chinese Market

46) What Customers Seek in a CRO

47) Selection Criteria

48) Keys to Outsourcing Success

49) What the Pharma Industry Spends on R&D

50) What Pharma Spends on Outsourcing

51) Clinical & Pre-clinical Research

52) Pre-Pharma Model

53) Partnering Model

54) What business are we in and what business do we want to be in?

55) How does my unique technology become a market opportunity?

56) What services will we provide?

57) How will we attract and sell customers?

58) What should we do to make sure the assignment is successful?

If you are one of the key CRO players and want to share your successful stories or want to be part of it, please join us now!.

Emily Liu
Project Leader
The Organizing Committee of IDDST 2008
BIT Life Sciences
26 Gaoneng St . , F4
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799609x810
Fax: 0086-0411-84799629
Email: emily@iddst.com

Annie Sun
Group Leader of IDDST 2008
26 Gaoneng St . , F4
Dalian Hightech Zone
Dalian , LN 116025, China
Tel:0086-411-84799479
Fax: 0086-0411-84799629
Email: annie@iddst.com